Shang Hai Zheng Quan Bao·2026-01-04 22:51Core Viewpoint - Zhejiang Huakang Pharmaceutical Co., Ltd. announced that certain controlling shareholders and their concerted actors have engaged in a pledge-style repurchase transaction extension with CITIC Securities, involving a total of 25,500,000 shares, which accounts for 8.41% of the company's total share capital [1][2]. Group 1: Share Pledge Details - The controlling shareholders, Cheng Xinping, Xu Xiaorong, and Yu Jianming, hold 16,685,055 shares (5.51%), 15,691,337 shares (5.18%), and 13,143,335 shares (4.34%) respectively [1]. - Cheng Xinping pledged 9,000,000 shares, Xu Xiaorong pledged 9,500,000 shares, and Yu Jianming pledged 7,000,000 shares to CITIC Securities [1]. - The pledged shares do not involve guarantees for major asset restructuring performance compensation or other security purposes [2]. Group 2: Cumulative Pledge Situation - As of the announcement date, the cumulative pledge situation of the controlling shareholders and their concerted actors is being disclosed [3]. - The announcement also includes details regarding the pledge of shares by shareholders holding more than 5% of the company [5].